Chapter 11: Pain Assessment

Pain Assessment thoroughly explores the neuroanatomic pathways of human discomfort, sharply distinguishing between nociceptive pain—which follows the predictable physiologic phases of transduction, transmission, perception, and modulation after tissue injury—and neuropathic pain, which stems from abnormal signal processing within the somatosensory nervous system and frequently evolves into a difficult-to-treat chronic condition. The text systematically categorizes pain by its origin, outlining visceral, somatic, cutaneous, and referred pain mechanisms, while also classifying it by duration to contrast acute, self-limiting episodes against persistent, chronic pain and sudden breakthrough pain. A significant portion of the chapter is dedicated to lifespan and developmental considerations, establishing that infants possess full pain capacity requiring specialized behavioral evaluations like the CRIES and FLACC scales, while simultaneously dismantling the dangerous clinical myth that pain is a normal expectation of the aging process. It also highlights specialized observational techniques for older adults with dementia utilizing the PAINAD scale. Furthermore, the material integrates critical systemic factors influencing the pain experience, including sex differences, cultural environments, social determinants of health, and the profound impact of the modern opioid epidemic, which requires clinicians to carefully balance mu-opioid receptor-based pain management against the risks of physical dependence. Emphasizing that subjective patient self-reporting remains the absolute gold standard for diagnosis, the chapter instructs students on utilizing the comprehensive PQRST mnemonic alongside a variety of unidimensional and multidimensional rating tools, such as the Brief Pain Inventory, numeric scales, and the Faces Pain Scale-Revised. Finally, the text transitions into objective clinical data collection, guiding healthcare professionals to accurately identify nonverbal autonomic behaviors, physiological distress markers, and complex abnormal pathologies like chemotherapy-induced peripheral neuropathy and Complex Regional Pain Syndrome (CRPS) to ensure holistic and effective patient intervention.